Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

Share Price is delayed by 15 minutes
Get Live Data
202.80    4.40 (2.22%)
Bid:
202.80
Ask:
203.00
Spread: 0.20 (0.099%)
Market Cap: £1.75b
PFD Live PriceLast checked at - London Stock Exchange

Intraday Premier Foods Share Chart

Directorate Change

14 Mar 2018 13:53

RNS Number : 7373H
Premier Foods plc
14 March 2018
 

 

 

Premier Foods plc ("Premier Foods" or the "Company")

14 March 2018

 

Board Retirement

 

Premier Foods announces that Tsunao Kijima, non-executive director, has advised the Company today that he intends to stand down as a director of Premier Foods on 23 March 2018, following his decision to retire from Nissin Foods Holdings Company Ltd ("Nissin"). Mr Kijima has served on the Board since July 2016 pursuant to the terms of the Relationship Agreement between the Company and Nissin.

 

Board Appointment

 

Following Mr Kijima's retirement, Shinji Honda will be appointed as a non-executive director and as Nissin's representative director pursuant to the Relationship Agreement, with effect from 23 March 2018.

 

Mr Honda is Chief Strategy Officer of Nissin, with responsibility for overseas operations, including Europe. Prior to joining Nissin in January 2018, Mr Honda spent his entire professional career at Takeda Pharmaceutical Company Limited ("Takeda"), a leading Japanese pharmaceutical company. He was named Member of the Board of Takeda in June 2013 and Corporate Strategy Officer in October 2014, having previously spent a significant amount of time overseeing Takeda's international operations where his responsibilities included President and CEO of Takeda North America.

 

Commenting on the changes Keith Hamill, Chairman of Premier Foods, said "I would like to take this opportunity to thank Mr Kijima for his significant contribution to both the Board and the partnership between Premier and Nissin, which has helped to ensure the successful launch of a number of exciting new products to market. We welcome Mr Honda to the Board and look forward to working with him in the future".

 

Mr Honda served as Member of the Board of Takeda Pharmaceutical Company Limited (listed on the first section of the Tokyo Stock Exchange) from June 2013 until June 2017. No further information is required to be disclosed pursuant to LR 9.6.13 R.

For further information please contact:

Andrew McDonald, General Counsel & Company Secretary +44 (0) 1727 815 850

Hannah Collyer, Corporate Affairs Director +44 (0) 1727 815 850

Richard Godden, Director of Investor Relations +44 (0) 1727 815 850

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAXZLFFVXFEBBF
Date   Source Headline
18th Jul 20247:00 amRNSQuarter 1 Trading Update
14th Jun 202412:00 pmRNSDirector/PDMR Shareholding
13th Jun 202411:39 amRNSDirector/PDMR Shareholding
6th Jun 202412:00 pmRNSNotice of AGM
30th May 202410:32 amRNSDirector/PDMR Shareholding
28th May 20243:38 pmRNSDirector/PDMR Shareholding
22nd May 202412:14 pmRNSDirector/PDMR Shareholding
16th May 20247:00 amRNSPreliminary Results
13th May 20247:00 amRNSDirectorate Change
23rd Apr 20249:00 amRNSNotice of Results
2nd Apr 202410:00 amRNSBlock listing Interim Review
2nd Apr 20249:00 amRNSTotal Voting Rights
27th Mar 202411:54 amRNSDirector/PDMR Shareholding
19th Mar 202411:19 amRNSDirector/PDMR Shareholding
15th Mar 202411:32 amRNSDirector/PDMR Shareholding
12th Mar 202410:54 amRNSDirector/PDMR Shareholding
8th Mar 202410:08 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSSuspension of pension deficit payments
1st Feb 20249:00 amRNSTotal Voting Rights
23rd Jan 20247:00 amRNSQ3 Trading Update
2nd Jan 20249:00 amRNSTotal Voting Rights
20th Dec 202311:05 amRNSDirector/PDMR Shareholding
13th Dec 20239:00 amRNSHolding(s) in Company
7th Dec 202311:59 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
29th Nov 202312:00 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSHalf-year results
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20237:00 amRNSAcquisition of FUEL10K
2nd Oct 20239:30 amRNSBlock listing Interim Review
2nd Oct 20239:00 amRNSTotal Voting Rights
1st Sep 20239:00 amRNSTotal Voting Rights
3rd Aug 20231:00 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
20th Jul 20234:27 pmRNSResult of AGM
20th Jul 20237:00 amRNSQ1 Trading Update
12th Jul 20234:03 pmRNSDirectorate Change
3rd Jul 20239:00 amRNSTotal Voting Rights
21st Jun 20237:50 amRNSDirector Declaration
9th Jun 20233:43 pmRNSDirector/PDMR Shareholding
6th Jun 20231:01 pmRNSNotice of AGM
1st Jun 20239:00 amRNSTotal Voting Rights
23rd May 20233:17 pmRNSDirector/PDMR Shareholding
19th May 202312:02 pmRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSPreliminary Results
2nd May 20239:00 amRNSTotal Voting Rights
3rd Apr 20239:30 amRNSBlock listing Interim Review
3rd Apr 20239:00 amRNSTotal Voting Rights
7th Mar 20237:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.